- Home
- DAVE vs ATRC Comparison
DAVE vs ATRC Comparison
Compare DAVE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVE
- ATRC
- Stock Information
- Founded
- DAVE 2017
- ATRC 2000
- Country
- DAVE United States
- ATRC United States
- Employees
- DAVE N/A
- ATRC N/A
- Industry
- DAVE Retail: Computer Software & Peripheral Equipment
- ATRC Medical/Dental Instruments
- Sector
- DAVE Technology
- ATRC Health Care
- Exchange
- DAVE Nasdaq
- ATRC Nasdaq
- Market Cap
- DAVE 2.9B
- ATRC 1.6B
- IPO Year
- DAVE N/A
- ATRC 2005
- Fundamental
- Price
- DAVE $279.80
- ATRC $31.54
- Analyst Decision
- DAVE Strong Buy
- ATRC Strong Buy
- Analyst Count
- DAVE 6
- ATRC 10
- Target Price
- DAVE $227.50
- ATRC $49.60
- AVG Volume (30 Days)
- DAVE 481.2K
- ATRC 400.6K
- Earning Date
- DAVE 08-04-2025
- ATRC 07-29-2025
- Dividend Yield
- DAVE N/A
- ATRC N/A
- EPS Growth
- DAVE N/A
- ATRC N/A
- EPS
- DAVE 3.70
- ATRC N/A
- Revenue
- DAVE $381,425,000.00
- ATRC $480,076,000.00
- Revenue This Year
- DAVE $37.77
- ATRC $14.63
- Revenue Next Year
- DAVE $17.77
- ATRC $12.62
- P/E Ratio
- DAVE $75.62
- ATRC N/A
- Revenue Growth
- DAVE 39.31
- ATRC 15.79
- 52 Week Low
- DAVE $28.74
- ATRC $20.20
- 52 Week High
- DAVE $283.19
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- DAVE 73.24
- ATRC 43.55
- Support Level
- DAVE $252.01
- ATRC $30.85
- Resistance Level
- DAVE $280.31
- ATRC $33.15
- Average True Range (ATR)
- DAVE 16.78
- ATRC 1.01
- MACD
- DAVE 3.61
- ATRC -0.10
- Stochastic Oscillator
- DAVE 96.50
- ATRC 30.00
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.